Search results
Alumis readies IPO to fund rival drug to Bristol Myers’ Sotyktu
BioPharma Dive via Yahoo Finance· 7 days agoVentyx Biosciences, another TYK2 drug developer with a similar IPO pitch to Alumis, lost most of its...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 7 days agoJ INTS BIO, ASCO 2024 - JIN-A02 showed tumor reductions including brain metastasis in the ongoing first-in-human, dose-finding Phase 1 clinical study PR ...
Pfizer (PFE) Phase III DMD Gene Therapy Study Misses Goal
Zacks via Yahoo Finance· 4 days agoPfizer's (PFE) phase III study, CIFFREO, fails to show improvement in motor function in ambulatory...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 3 days agoAcross three doses, patients with diabetic peripheral neuropathy reported at least a 2-point...
Indiana University to create new chancellor position for Bloomington campus
Gannett via AOL· 2 days ago“I sincerely believe that these two vital additions will begin the process of unlocking the...
Pilot Study in JNCCN Explores New Approach for Reducing Anxiety and Improving Quality of Life after...
The Woonsocket Call· 5 days agoThe study used a randomized clinical trial to evaluate the feasibility of a nine-week, phone-delivered, positive psychology program called Positive Affect ...
Medical school students, physicians present projects at PCOM South Georgia’s annual Research Day
The Moultrie Observer, Ga. via Yahoo News· 2 days agoMOULTRIE – Practicing physicians, residents and medical school students gathered to share their current research projects and learn about ongoing investigations during PCOM South Georgia PCOM ...
Is bariatric surgery still best? What new research says about the procedure as weight loss drugs...
Yahoo Life· 2 days agoThe latest studies assure safety and permanence, address the overall value cost and even present...
Lipocine Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late Breaking Session at EASL...
The Herald Journal· 7 days agoSanyal, MD, Director, Stravitz-Sanyal Institute...
Lixte Biotechnology inks deal for cancer drug trial By Investing.com
Investing.com· 3 days ago(NASDAQ:LIXT) has entered into a significant agreement with the Netherlands Cancer Institute (NKI)...